Announcements Trials
Browse Landscape

Phase

Phase 2 173Phase 1 113Phase 1/2 92Phase 3 36Phase EARLY_PHASE1 5Phase 2/3 5Phase NA 3Phase 4 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 6Head & Neck 4Gastrointestinal 3Dermatologic 3Gynecologic 2Genitourinary 2Tumor-Agnostic 1CNS 1

Conditions

Carcinoma, Hepatocellular 2Liver Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

Colonoscopy 67Blood Specimen Collection 64Standard of Care 60Exercise 59Radiosurgery 53Drug Therapy 49Radiofrequency Ablation 47Endoscopic Mucosal Resection 47Radiotherapy 45Surgical Procedures, Operative 44Methods 43Early Intervention, Educational 40Surveys and Questionnaires 39Oxaliplatin 38Laparoscopy 34Educational Status 34Fluorouracil 33Magnetic Resonance Spectroscopy 28Gemcitabine 26Biopsy 26Preoperative Exercise 25Practice Guidelines as Topic 24Control Groups 24lenvatinib 23Patient Navigation 23Electroporation 23Capecitabine 22camrelizumab 20Saline Solution 20Liver Transplantation 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × pembrolizumab × Gastrointestinal × Clear all
NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Sichuan University

Phase NA Not yet recruiting
98 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05339581 2022-04-27

iPLENTY-pvtt

RenJi Hospital

Phase NA Unknown
78 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05233358 2022-02-10

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

The Central Hospital of Lishui City

Phase NA Unknown
176 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡